EP2201135 - INDIVIDUALIZED CANCER TREATMENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 29.07.2011 Database last updated on 06.11.2024 | Most recent event Tooltip | 29.07.2011 | Application deemed to be withdrawn | published on 31.08.2011 [2011/35] | Applicant(s) | For all designated states Duke University 2812 Erwin Road, Suite 306 Durham, NC 27705 / US | [2010/26] | Inventor(s) | 01 /
POTTI, Anil 101 Lake Ridge Place Chapel Hill NC 27516 / US | 02 /
DRESSMAN, Holly, K. 4606 Carlton Crossing Drive Durham NC 27713 / US | 03 /
NEVINS, Joseph, R. 100 York Place Chapel Hill NC 27517 / US | [2010/26] | Representative(s) | Kehoe, Laura Ellen, et al Keltie LLP No.1 London Bridge London SE1 9BA / GB | [N/P] |
Former [2010/26] | Kehoe, Laura Ellen, et al Keltie Fleet Place House 2 Fleet Place London EC4M 7ET / GB | Application number, filing date | 08833249.9 | 29.09.2008 | [2010/26] | WO2008US78150 | Priority number, date | US20070995910P | 28.09.2007 Original published format: US 995910 P | [2010/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009043022 | Date: | 02.04.2009 | Language: | EN | [2009/14] | Type: | A2 Application without search report | No.: | EP2201135 | Date: | 30.06.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.04.2009 takes the place of the publication of the European patent application. | [2010/26] | Search report(s) | International search report - published on: | EP | 16.07.2009 | Classification | IPC: | C12Q1/68 | [2010/26] | CPC: |
C12Q1/6886 (EP,US);
A61P35/00 (EP);
C12Q2600/106 (EP,US);
C12Q2600/158 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/26] | Extension states | AL | Not yet paid | BA | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | INDIVIDUALISIERTE KREBSBEHANDLUNGEN | [2010/26] | English: | INDIVIDUALIZED CANCER TREATMENTS | [2010/26] | French: | TRAITEMENTS DU CANCER INDIVIDUALISÉS | [2010/26] | Entry into regional phase | 27.04.2010 | National basic fee paid | 27.04.2010 | Designation fee(s) paid | 27.04.2010 | Examination fee paid | Examination procedure | 27.04.2010 | Examination requested [2010/26] | 30.06.2010 | Amendment by applicant (claims and/or description) | 13.10.2010 | Despatch of a communication from the examining division (Time limit: M04) | 24.02.2011 | Application deemed to be withdrawn, date of legal effect [2011/35] | 31.03.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/35] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 13.10.2010 | Fees paid | Renewal fee | 24.08.2010 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X] - "Affymetrix GeneChip Human Genome U133 Array Set HG-U133A", GEO,, (20020311), XP002254749 [X] 34 * the whole document * | [X] - "Single-sided, three-layer HD-DVD", III VS REVIEW, ELSEVIER SCIENCE PUBLISHERS, OXFORD, GB, vol. 19, no. 7, ISSN 0961-1290, (20060901), page 12, (20060901), XP025108945 [X] 36 * the whole document * DOI: http://dx.doi.org/10.1016/S0961-1290(06)71795-1 | [YD] - POTTI ANIL ET AL, "Genomic signatures to guide the use of chemotherapeutics", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 12, no. 11, ISSN 1078-8956, (20061101), pages 1294 - 130, (20061027), XP002494154 [YD] 1-12,24-28 * abstract * * page 1294 - page 1297 * * page 1299 - page 1300 * * figure 6 * DOI: http://dx.doi.org/10.1038/nm1491 | [ ] - POTTI ANIL ET AL, "Supplementary online material of Genomic signatures to guide the use of chemotherapeutics", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 12, no. 11, (20061101), URL: http://www.nature.com/nm/journal/v12/n11/suppinfo/nm1491_S1.html, (20090206), XP002513949 [ ] * figure s2 * * pages 3-4 * * pages 6-8 * | [YD] - GYORFFY BALAZS ET AL, "Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations", INTERNATIONAL JOURNAL OF CANCER, (200604), vol. 118, no. 7, ISSN 0020-7136, pages 1699 - 1712, XP002513950 [YD] 1-12,24-28 * page 1699 * * page 1701 - page 1706 * * figure 2 * DOI: http://dx.doi.org/10.1002/ijc.21570 | [PX] - HSU DAVID S ET AL, "Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.", JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY 1 OCT 2007, (20071001), vol. 25, no. 28, ISSN 1527-7755, pages 4350 - 4357, XP002513951 [PX] 1-12,24-28,34 * the whole document * DOI: http://dx.doi.org/10.1200/JCO.2007.11.0593 | [A] - GIOVANNETTI ELISA ET AL, "Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells", MOLECULAR PHARMACOLOGY, (200507), vol. 68, no. 1, ISSN 0026-895X, pages 110 - 118 URL, XP002513966 [A] 1-12,24-28 * abstract * DOI: http://dx.doi.org/10.1124//MOL.104.009373 | Examination | - SANDERCOCK J ET AL, "First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence.", BRITISH JOURNAL OF CANCER 7 OCT 2002 LNKD- PUBMED:12373593, (20021007), vol. 87, no. 8, ISSN 0007-0920, pages 815 - 824, XP007914845 | - LEBWOHL D ET AL, "Clinical development of platinum complexes in cancer therapy: an historical perspective and an update", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB LNKD- DOI:10.1016/S0959-8049(98)00224-X, (19980901), vol. 34, no. 10, ISSN 0959-8049, pages 1522 - 1534, XP004285042 DOI: http://dx.doi.org/10.1016/S0959-8049(98)00224-X |